Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHA:600671)
14.75
-0.30 (-1.99%)
Nov 18, 2026, 3:00 PM CST
SHA:600671 Revenue
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd had revenue of 50.43M CNY in the quarter ending September 30, 2026, a decrease of -8.88%. This brings the company's total for the last twelve months to 202.59M, down -19.46% year-over-year. In the year 2025, Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd had annual revenue of 211.75M, down -2.55%. That makes Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd the 31,311th largest company in the world by revenue and 5,008th in China.
Revenue (ttm)
202.59M
Revenue Growth
-19.46%
P/S Ratio
9.05
Revenue / Employee
516.82K
Employees
392
Market Cap
1.80B
Revenue by Segment
- Health Care Products 90.99M 43.0%
- Circulating Commodities 50.35M 23.8%
- Active Pharmaceutical Ingredient (API) 30.30M 14.3%
- Chinese Patent Medicine 28.26M 13.3%
- Service Type 5.19M 2.5%
- Medical Instruments 3.79M 1.8%
- Chemical Medicine 1.84M 0.9%
- Other 979.71K 0.5%
Fiscal year ended Dec 31, 2025 See the full SHA:600671 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 211.75M | -5.54M | -2.55% |
| Dec 31, 2024 | 217.30M | 95.52M | 78.44% |
| Dec 31, 2023 | 121.78M | 12.87M | 11.82% |
| Dec 31, 2022 | 108.91M | -38.16M | -25.95% |
| Dec 31, 2021 | 147.07M | -59.56M | -28.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Int'l Group | 34.69B |
| Shanghai Shenqi Pharmaceutical Investment Management | 1.80B |
| Zhejiang Zhenyuan Share | 1.79B |
| GuangYuYuan Chinese Herbal Medicine | 1.31B |
| Hangzhou Minsheng Healthcare | 902.62M |
| Hubei Guangji Pharmaceutical | 630.16M |
| Hangzhou Bio-Sincerity Pharma-Tech | 617.95M |
| Aurora Optoelectronics | 604.05M |